Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Savara Pharmaceuticals
DescriptionNebulized form of recombinant human GM-CSF
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II/III
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune pulmonary alveolar proteinosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today